Ashland Inc. (ASH) Earnings Call Analysis

NYSE · Basic Materials · Specialty Chemicals

Earnings Reports

• Ashland (ASH) Q3 2026: 7% Sales Growth as Globalize and Innovate Surpass Annual Targets
  July 29, 2026
• Ashland (ASH) Q2 2026: EBITDA Slips 9% as Operational Setbacks Offset Innovation Surge
  April 29, 2026
• Ashland (ASH) Q1 2026: Specialty Additives Margin Expands 340bps as Innovation Offsets Demand Weakness
  February 03, 2026
• Ashland (ASH) Q4 2025: Portfolio Optimization Drives 110bps Margin Expansion as Cost Actions Take Hold
  November 05, 2025
• Ashland (ASH) Q3 2025: $60M Cost Optimization Set to Unlock Margin Upside Amid Muted Demand
  July 30, 2025
• Ashland (ASH) Q2 2025: Portfolio Optimization Drives 350bps Margin Gain in Personal Care
  July 06, 2025
• Ashland (ASH) Q4 2024: EBITDA Margin Jumps 950bps as Portfolio Reset Drives Mix Shift
  August 07, 2024
• Ashland (ASH) Q3 2024: Personal Care Grows 20% as VPND Pharma Share Loss Cuts Outlook
  August 07, 2024
• Ashland (ASH) Q2 2024: Personal Care Up 30% Sequentially as Demand Normalization Drives Margin Rebound
  May 01, 2024
• Ashland (ASH) Q1 2024: $136M Inventory Reduction Resets Operating Leverage Ahead of Demand Rebound
  January 31, 2024
• Ashland (ASH) Q4 2023: $200M Portfolio Pruning Targets 250bps Margin Expansion Amid Prolonged Destocking
  November 09, 2023

Browse all companies